Analgesic Efficacy of Blocking Nerve to Vastus Lateralis Muscle Versus Lateral Femoral Cutaneous Nerve After Knee Surgeries

NCT06809842 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2025-02-06

No results posted yet for this study

Summary

This study aims to compare the analgesic efficacy and functional outcomes of blocking the nerve to the vastus lateralis (NVL) muscle versus the lateral femoral cutaneous nerve (LFCN).

Conditions

  • Analgesia
  • Vastus Lateralis Nerve Block
  • Lateral Femoral Cutaneous Nerve Block
  • Knee Surgeries

Interventions

DRUG

Vastus lateralis nerve block

Patients received vastus lateralis nerve block with 5 ml of bupivacaine 0.5%.

DRUG

Lateral femoral cutaneous nerve block

Patients received lateral femoral cutaneous nerve block with 5 ml of bupivacaine 0.5%.

Sponsors & Collaborators

  • Kafrelsheikh University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-02-05
Primary Completion
2025-07-30
Completion
2025-07-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06809842 on ClinicalTrials.gov